Literature DB >> 7444721

Unstable aryl hydrocarbon hydroxylase-deficient variants of a rat hepatoma line.

O Hankinson.   

Abstract

The H-4-II-E-C3 line has high aryl hydrocarbon hydroxylase (AHH) activity. It was also found to be very sensitive to benzo(a)pyrene (BP) toxicity, and a single-step selection procedure for isolating BP-resistant (BPr) clones was designed. All the BPr variants tested had reduced AHH activities under both inducing and noninducing conditions. As H-4-II-E-C3 was propagated, it gradually declined in AHH activity and increased in cloning efficiency in BP. The spontaneous rate of origin of the BPr variants was approximately 3 x 10(-5) events per cell generation. However, the variants gradually increased in AHH activity and decreased in cloning efficiency in BP as they were propagated. Partially resistant variants also generated, at an appreciable rate, cells with even greater degrees of resistance to BP. The instabilities of the wild-type and variant cultures suggest that the variants arose by an epigenetic mechanism or by changes in gene dosage, rather than by point mutations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7444721     DOI: 10.1007/bf01538974

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  3 in total

1.  Comparison of CYP1A1 induction and genotoxicity in vitro as indicators of potentially harmful effects of environmental samples.

Authors:  P Kopponen; R Törrönen; J Mäki-Paakkanen; A von Wright; S Kärenlampi
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

2.  Cinnabarinic Acid-Induced Stanniocalcin 2 Confers Cytoprotection against Alcohol-Induced Liver Injury.

Authors:  Aditya D Joshi; Gopal Thinakaran; Cornelis Elferink
Journal:  J Pharmacol Exp Ther       Date:  2022-01-25       Impact factor: 4.030

3.  Transfection by genomic DNA of cytochrome P1-450 enzymatic activity and inducibility.

Authors:  D F Montisano; O Hankinson
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.